Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05424354 · ClinicalTrials.gov registry record · Phase 4
Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing
A Phase 4 study of Wounds and Injuries, sponsored by ULURU.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 6
- Study locations
NCT05424354 is a Phase 4 study of Wounds and Injuries that is actively recruiting participants, run by ULURU. The registered enrollment target is 60 participants, below the 502-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (88% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT05424354, a Phase 4 study of Wounds and Injuries, is actively recruiting participants, sponsored by ULURU.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study is being performed to assess the effectiveness of Altrazeal(R) Transforming Powder Dressing (TPD) in patients with partial thickness burns compared to the current standard of care (SOC) dressing. Adult men and women 18-65 years old who are hospitalized with an acute (meaning the burn injury occurred less than 72 hours prior to enrollment in the study) partial thickness burn wound, less than 20 percent of total body surface area may be considered. Subjects will be randomized in a 1:1 ratio to either SOC or TPD. Subjects will be followed for up to 28 days after enrollment.
Conditions Studied
Interventions
- DEVICE Altrazeal (R) Transforming Powder Dressing
- OTHER Standard of Care burn dressing
Study Locations (6)
California
- University of California-Irvine - Orange
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Florida
- Jackson Memorial Hospital UM/JMH Burn Center - Miami
Kentucky
- University of Louisville Health - Louisville
New York
- Westchester Medical Center - Valhalla
Texas
- University of Texas SW (Parkland) - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-05-26 |
| Est. Completion | 2026-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05424354
The ClinicalTrials.gov registry entry for NCT05424354 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 502-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (88% lower). The listed sponsor is ULURU, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Wounds and Injuries appearing as the primary indexed condition, and to 2 interventions - of which Altrazeal (R) Transforming Powder Dressing is the first listed.
NCT05424354 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, District of Columbia, Florida.
Frequently Asked Questions
What is clinical trial NCT05424354 about?
NCT05424354 is a clinical study titled "Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing". This study is being performed to assess the effectiveness of Altrazeal(R) Transforming Powder Dressing (TPD) in patients with partial thickness burns compared to the current standard of care (SOC) dressing. Adult men and women 18-65 years old who are hospitalized with an acute (meaning the burn inju...
What is the current status of trial NCT05424354?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2022-05-26. Estimated completion is 2026-09-30.
What conditions does trial NCT05424354 study?
This clinical trial studies the following conditions: Wounds and Injuries.
What interventions are being tested in trial NCT05424354?
The interventions under investigation include: Altrazeal (R) Transforming Powder Dressing (DEVICE), Standard of Care burn dressing (OTHER).
Who is sponsoring clinical trial NCT05424354?
This trial is sponsored by ULURU, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05424354 being conducted?
This trial has 6 study locations across California, District of Columbia, Florida, Kentucky, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wounds and Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients
COMPLETED · Phase 4
-
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
RECRUITING · Phase 3
-
Effect of Giving Reduced Fluid in Children After Trauma
RECRUITING · NA
-
Blood Flow Restriction Training After Patellar INStability
RECRUITING · NA
-
Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness
RECRUITING · NA
-
Pediatric Prehospital Airway Resuscitation Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.